Naringenin in combination with quercetin/fisetin shows synergistic anti-proliferative and migration reduction effects in breast cancer cell lines

[1]  M. Muddassir,et al.  Antiproliferative Mechanisms of a Polyphenolic Combination of Kaempferol and Fisetin in Triple-Negative Breast Cancer Cells , 2023, International journal of molecular sciences.

[2]  D. Barreca,et al.  Targets Involved in the Anti-Cancer Activity of Quercetin in Breast, Colorectal and Liver Neoplasms , 2023, International journal of molecular sciences.

[3]  Khaled S. Allemailem,et al.  The Potential Role of Fisetin, a Flavonoid in Cancer Prevention and Treatment , 2022, Molecules.

[4]  B. Nielsen,et al.  MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells. , 2022, Journal of hepatology.

[5]  Nikita Devnarain,et al.  Synergism Potentiates Oxidative Antiproliferative Effects of Naringenin and Quercetin in MCF-7 Breast Cancer Cells , 2022, Nutrients.

[6]  S. Yeap,et al.  Unveiling the tumour-regulatory roles of miR-1275 in cancer. , 2021, Pathology, research and practice.

[7]  J. Baharara,et al.  Apoptosis Induction with Combined Use of Cisplatin and Fisetin in Cisplatin-Resistant Ovarian Cancer Cells (A2780) , 2021, Avicenna journal of medical biotechnology.

[8]  Azam Khedri,et al.  Quercetin Potentiates the Chemosensitivity of Human Breast Cancer Cells to 5-Fluorouracil , 2021 .

[9]  Mojtaba Rashidi,et al.  Quercetin synergistically potentiates the anti-metastatic effect of 5-fluorouracil on the MDA-MB-231 breast cancer cell line. , 2021, Iranian journal of basic medical sciences.

[10]  E. Heidarian,et al.  Quercetin Synergistically Enhances the Anticancer Efficacy of Docetaxel through Induction of Apoptosis and Modulation of PI3K/AKT, MAPK/ERK, and JAK/STAT3 Signaling Pathways in MDA-MB-231 Breast Cancer Cell Line , 2021, International journal of molecular and cellular medicine.

[11]  Yue Liu,et al.  Quercetin inhibits invasion and angiogenesis of esophageal cancer cells. , 2021, Pathology, research and practice.

[12]  M. Shariati,et al.  Fisetin: An anticancer perspective , 2020, Food science & nutrition.

[13]  M. Ramasamy,et al.  Synergistic and enhanced anticancer effect of a facile surface modified non-cytotoxic silver nanoparticle conjugated with gemcitabine in metastatic breast cancer cells , 2020 .

[14]  B. Yousefi,et al.  A review on anti-cancer properties of Quercetin in breast cancer. , 2020, Life sciences.

[15]  L. Ahmadi,et al.  Therapeutic potential of quercetin on human breast cancer in different dimensions , 2019, Inflammopharmacology.

[16]  Gang Yang,et al.  MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations , 2019, Front. Oncol..

[17]  Jing Tang,et al.  DrugComb: an integrative cancer drug combination data portal , 2019, Nucleic Acids Res..

[18]  Manoj Kumar,et al.  Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential , 2019, Biomolecules.

[19]  Zhenjiang Zhao,et al.  Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways , 2019, Inflammopharmacology.

[20]  Guo-ping Ding,et al.  Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways , 2019, Cell Death & Disease.

[21]  S. Samuel,et al.  Flavonoids in Cancer and Apoptosis , 2018, Cancers.

[22]  A. Srinivasan,et al.  Synergistic anticancer action of quercetin and curcumin against triple‐negative breast cancer cell lines , 2018, Journal of cellular physiology.

[23]  Jun Zhou,et al.  Naringenin has a chemoprotective effect in MDA-MB-231 breast cancer cells via inhibition of caspase-3 and -9 activities. , 2018, Oncology letters.

[24]  W. Yeh,et al.  Fisetin inhibits cell migration via inducing HO-1 and reducing MMPs expression in breast cancer cell lines. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[25]  J. Wan,et al.  Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway , 2018, Front. Pharmacol..

[26]  Ping Liu,et al.  Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway. , 2018, Gene.

[27]  Qi-wei Li,et al.  Anti-cancer effects of fisetin on mammary carcinoma cells via regulation of the PI3K/Akt/mTOR pathway: In vitro and in vivo studies , 2018, International journal of molecular medicine.

[28]  A. Pawar,et al.  Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting , 2018, Artificial cells, nanomedicine, and biotechnology.

[29]  Lifang Wang,et al.  Carnosic acid and fisetin combination therapy enhances inhibition of lung cancer through apoptosis induction. , 2017, International journal of oncology.

[30]  X. Miao,et al.  Fisetin inhibits liver cancer growth in a mouse model: Relation to dopamine receptor , 2017, Oncology reports.

[31]  Lei Wang,et al.  Bioflavonoid Fisetin Loaded α-Tocopherol-Poly(lactic acid)-Based Polymeric Micelles for Enhanced Anticancer Efficacy in Breast Cancers , 2017, Pharmaceutical Research.

[32]  Sheela Chandra,et al.  Flavonoids: an overview , 2016, Journal of Nutritional Science.

[33]  Eiman Mukhtar,et al.  Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells , 2016, Molecular Cancer Therapeutics.

[34]  D. Hoskin,et al.  The Dietary Flavonoid Fisetin Causes Cell Cycle Arrest, Caspase‐Dependent Apoptosis, and Enhanced Cytotoxicity of Chemotherapeutic Drugs in Triple‐Negative Breast Cancer Cells , 2016, Journal of cellular biochemistry.

[35]  Yulong Yin,et al.  Quercetin, Inflammation and Immunity , 2016, Nutrients.

[36]  A. Yalçın,et al.  Quercetin-Induced Cell Death in Human Papillary Thyroid Cancer (B-CPAP) Cells , 2016, Journal of thyroid research.

[37]  Hai-yan Song,et al.  Effect of quercetin on the proliferation of the human ovarian cancer cell line SKOV-3 in vitro. , 2015, Experimental and therapeutic medicine.

[38]  K. Straif,et al.  Breast-cancer screening--viewpoint of the IARC Working Group. , 2015, The New England journal of medicine.

[39]  Zhong-Zhen Zhao,et al.  Combinational Treatment of Curcumin and Quercetin against Gastric Cancer MGC-803 Cells in Vitro , 2015, Molecules.

[40]  Shree Ram Singh,et al.  The emerging roles of microRNAs in cancer metabolism. , 2015, Cancer letters.

[41]  Jer‐Yuh Liu,et al.  Naringenin inhibits migration of bladder cancer cells through downregulation of AKT and MMP‑2. , 2014, Molecular medicine reports.

[42]  W. Guo,et al.  Melatonin Enhances the Anti-Tumor Effect of Fisetin by Inhibiting COX-2/iNOS and NF-κB/p300 Signaling Pathways , 2014, PloS one.

[43]  N. Xing,et al.  Quercetin synergizes with 2-methoxyestradiol inhibiting cell growth and inducing apoptosis in human prostate cancer cells. , 2013, Oncology reports.

[44]  Jun Zhao,et al.  Anticancer effect and apoptosis induction by quercetin in the human lung cancer cell line A-549. , 2011, Molecular medicine reports.

[45]  Pei-Ming Yang,et al.  Dietary flavonoid fisetin targets caspase-3-deficient human breast cancer MCF-7 cells by induction of caspase-7-associated apoptosis and inhibition of autophagy. , 2011, International journal of oncology.

[46]  A. Carrier,et al.  TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression , 2011, Oncogene.

[47]  S. Safe,et al.  MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells. , 2010, Endocrinology.

[48]  C. Croce,et al.  MicroRNAs as regulators of death receptors signaling , 2010, Cell Death and Differentiation.

[49]  H. Shirato,et al.  Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy. , 2010, Cancer research.

[50]  N. Normanno,et al.  Target-based therapies in breast cancer: current status and future perspectives. , 2009, Endocrine-related cancer.

[51]  H. Mukhtar,et al.  Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells. , 2008, Carcinogenesis.

[52]  C. Yiannoutsos,et al.  Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo , 2007, Molecular Cancer Therapeutics.

[53]  George P Cobb,et al.  microRNAs as oncogenes and tumor suppressors. , 2007, Developmental biology.

[54]  Tae-Jin Lee,et al.  Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells. , 2006, Cancer letters.

[55]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[56]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[57]  S. J. Lee,et al.  Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. , 2001, International journal of oncology.

[58]  M Naguib,et al.  Analysis of drug interactions. , 1995, Anesthesia and analgesia.

[59]  T. Sakai,et al.  The effect of quercetin on cell cycle progression and growth of human gastric cancer cells , 1990, FEBS letters.

[60]  Yuan Chen,et al.  MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1. , 2019, Cancer biomarkers : section A of Disease markers.

[61]  T. Chou,et al.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.

[62]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .